MoonLake Immunotherapeutics (MLTX) Total Debt (2021)
MoonLake Immunotherapeutics' Total Debt history spans 1 years, with the latest figure at $15.0 million for Q4 2021.
- Quarterly Total Debt changed N/A to $15.0 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $15.0 million through Dec 2021, changed N/A year-over-year, with the annual reading at $15.0 million for FY2021, N/A changed from the prior year.
- Total Debt came in at $15.0 million for Q4 2021.
- In the past five years, Total Debt ranged from a high of $15.0 million in Q4 2021 to a low of $15.0 million in Q4 2021.